Ai er Ophthalmology

This year, the Department of Ophthalmology has announced plans to take Macquarie Ophthalmology's Nanchong, Chongqing, Shijiazhuang under the three major outlets.　　Yesterday, Ai Seoul also announced plans to buy 38.8 million yuan and increase the capital of Tianjin Macquarie Eye Hospital. Ai Seoul Eye in the gem listing, with its ophthalmic medical characteristics of the original "three-level chain" business model to quickly realize the strategic layout of the national business Network, and will be completed this year, including Beijing and other provincial capital of the network radiation.　　"Three-level chain" is a first-level hospital in Shanghai AI Seoul as the center, to the provincial capital level two hospital as a stronghold to a prefecture-level three hospital for the terminal area coverage network. 2010 is the rapid expansion of the eye of Ai er, after the proposed 11 million yuan super raise funds to buy Nanchong eye, 5.6 million yuan to buy Chongqing Macquarie Ophthalmology, 25.5 million yuan to buy Shijiazhuang Macquarie Ophthalmic, more generous expansion plan followed-38.8 million yuan acquisition and increase capital expansion Tianjin Macquarie Eye Hospital,　　After the completion of the name of the Tianjin AI er Ophthalmic Hospital. Tianjin Macquarie Eye Hospital registered capital of 100,000 Yuan, 2008-year loss of 167,000 Yuan, 2009-year operating income of 4.207 million yuan, achieved a small turnover, net profit of 10,500 yuan.　　As at December 31, 2009, the company's total assets of 2.365 million yuan, net assets-3.489 million yuan. Ai Seoul to buy 500,000 yuan in Tianjin Macquarie 100% of the equity, and increase the capital of 38.3 million yuan for the expansion of the hospital, making it a large area in the Bohai Rim, a comprehensive range of modern ophthalmic hospital.　　According to the feasibility study report, the hospital is expected to have an annual profit of about 5.18 million yuan and a static investment recovery period of about 5 years. Tianjin Macquarie has an eye medical license qualification and is the medical insurance sentinel institutions, through the acquisition of Tianjin Macquarie, Ai er Eye can quickly enter the Tianjin ophthalmic market and radiation Beijing.